Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors.

Fabiani C, Vitale A, Emmi G, Sgheri A, Lopalco G, Sota J, Guerriero S, Iannone F, Frediani B, Vannozzi L, Bianco MT, Giovannini V, Tosi GM, Cantarini L.

Front Pharmacol. 2019 Dec 9;10:1468. doi: 10.3389/fphar.2019.01468. eCollection 2019.

2.

Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review.

Gaggiano C, Rigante D, Tosi GM, Vitale A, Frediani B, Grosso S, Fabiani C, Cantarini L.

Clin Rheumatol. 2019 Dec 10. doi: 10.1007/s10067-019-04763-3. [Epub ahead of print]

PMID:
31823144
3.

Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017.

Puzelli S, Di Martino A, Facchini M, Fabiani C, Calzoletti L, Di Mario G, Palmieri A, Affanni P, Camilloni B, Chironna M, D'Agaro P, Giannecchini S, Pariani E, Serra C, Rizzo C, Bella A, Donatelli I, Castrucci MR; Italian Influenza Laboratory Network.

BMC Infect Dis. 2019 Nov 21;19(1):990. doi: 10.1186/s12879-019-4621-z.

4.

Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema.

Tosi GM, Vitale A, Rigante D, Sota J, Emmi G, Lopalco G, Guerriero S, Iannone F, Vannozzi L, Bitossi A, Frediani B, Cantarini L, Fabiani C.

Clin Exp Rheumatol. 2019 Oct 17. [Epub ahead of print]

PMID:
31694738
5.

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.

Sota J, Rigante D, Ruscitti P, Insalaco A, Sfriso P, de Vita S, Cimaz R, Lopalco G, Emmi G, La Torre F, Fabiani C, Olivieri AN, Cattalini M, Cammelli D, Gallizzi R, Alessio M, Manna R, Viapiana O, Frassi M, Pardeo M, Maier A, Salvarani C, Talarico R, Mosca M, Colafrancesco S, Priori R, Maggio MC, Gaggiano C, Grosso S, De Benedetti F, Vitale A, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Aug 23;10:918. doi: 10.3389/fphar.2019.00918. eCollection 2019.

6.

Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease.

Lopalco G, Venerito V, Leccese P, Emmi G, Cantarini L, Lascaro N, Di Scala G, Fabiani C, Rigante D, Iannone F.

Ann Rheum Dis. 2019 Dec;78(12):1736-1737. doi: 10.1136/annrheumdis-2019-215437. Epub 2019 Aug 10. No abstract available.

PMID:
31401548
7.

Alzheimer's Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts.

Fabiani C, Antollini SS.

Front Cell Neurosci. 2019 Jul 18;13:309. doi: 10.3389/fncel.2019.00309. eCollection 2019. Review.

8.

Perioperative dental screening and treatment in patients undergoing cardio-thoracic surgery and interventional cardiovascular procedures. A consensus report based on RAND/UCLA methodology.

Cotti E, Cairo F, Bassareo PP, Fonzar F, Venturi M, Landi L, Parolari A, Franco V, Fabiani C, Barili F, Di Lenarda A, Gulizia M, Borzi M, Campus G, Musumeci F, Mercuro G.

Int J Cardiol. 2019 Oct 1;292:78-86. doi: 10.1016/j.ijcard.2019.06.041. Epub 2019 Jun 17.

PMID:
31262607
9.

Perioperative dental screening and treatment in patients undergoing cardiothoracic surgery and interventional cardiovascular procedures. A consensus report based on RAND/UCLA methodology.

Cotti E, Cairo F, Bassareo PP, Fonzar F, Venturi M, Landi L, Parolari A, Franco V, Fabiani C, Barili F, Di Lenarda A, Gulizia M, Borzi M, Campus G, Musumeci F, Mercuro G.

Int Endod J. 2020 Feb;53(2):186-199. doi: 10.1111/iej.13166. Epub 2019 Dec 20.

PMID:
31162683
10.

Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.

Tosi GM, Sota J, Vitale A, Rigante D, Emmi G, Lopalco G, Guerriero S, Orlando I, Iannone F, Frediani B, Angotti R, Messina M, Galeazzi M, Vannozzi L, Cantarini L, Fabiani C.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):680-683. Epub 2019 Apr 3.

11.

Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study.

Bitossi A, Bettiol A, Silvestri E, Di Scala G, Bacherini D, Lopalco G, Venerito V, Iannone F, Vitale A, Tosi GM, Prisco D, Rizzo S, Fabiani C, Cantarini L, Virgili G, Vannozzi L, Emmi G.

Mediators Inflamm. 2019 Feb 10;2019:1623847. doi: 10.1155/2019/1623847. eCollection 2019.

12.

Impact of Paternal Age on Seminal Parameters and Reproductive Outcome of Intracytoplasmatic Sperm Injection in Infertile Italian Women.

Gallo M, Licata E, Meneghini C, Dal Lago A, Fabiani C, Amodei M, Antonaci D, Miriello D, Corno R, Liberanome C, Bisogni F, Paciotti G, Meneghini C, Rago R.

Front Endocrinol (Lausanne). 2019 Feb 13;10:35. doi: 10.3389/fendo.2019.00035. eCollection 2019.

13.

Molecular Modulation of Human α7 Nicotinic Receptor by Amyloid-β Peptides.

Lasala M, Fabiani C, Corradi J, Antollini S, Bouzat C.

Front Cell Neurosci. 2019 Feb 8;13:37. doi: 10.3389/fncel.2019.00037. eCollection 2019.

14.

Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, Guerriero S, Bitossi A, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Exp Rheumatol. 2019 Mar-Apr;37(2):301-305. Epub 2019 Jan 18.

15.

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis.

Sota J, Insalaco A, Cimaz R, Alessio M, Cattalini M, Gallizzi R, Maggio MC, Lopalco G, La Torre F, Fabiani C, Pardeo M, Olivieri AN, Sfriso P, Salvarani C, Gaggiano C, Grosso S, Bracaglia C, De Benedetti F, Rigante D, Cantarini L.

Front Pharmacol. 2019 Jan 8;9:1526. doi: 10.3389/fphar.2018.01526. eCollection 2018.

16.

Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations.

Lucherini OM, Vitale A, Orlando I, Sota J, Fabiani C, Franceschini R, Simpatico A, Frediani B, Galeazzi M, Tosi GM, Cantarini L.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):110-115. Epub 2018 Dec 12.

PMID:
30582507
17.

Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy.

Lopalco G, Venerito V, Sota J, Rigante D, Guerriero S, Orlando I, Franceschini R, Favale R, Lapadula G, Castelli B, Frediani B, Galeazzi M, La Torre F, Iannone F, Tosi GM, Fabiani C, Cantarini L.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):68-73. Epub 2018 Dec 12.

PMID:
30582503
18.

Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease.

Vitale A, Emmi G, Lopalco G, Fabiani C, Gentileschi S, Silvestri E, Di Scala G, Iannone F, Frediani B, Galeazzi M, Lapadula G, Rigante D, Cantarini L.

Clin Rheumatol. 2019 Jan;38(1):267. doi: 10.1007/s10067-018-4302-0.

PMID:
30242638
19.

The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Di Scala G, Sota J, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Ocul Immunol Inflamm. 2018 Aug 27:1-7. doi: 10.1080/09273948.2018.1511810. [Epub ahead of print]

PMID:
30148652
20.

Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers.

Gentileschi S, Vitale A, Rigante D, Lopalco G, Emmi G, Orlando I, Di Scala G, Sota J, Fabiani C, Frediani B, Galeazzi M, Lapadula G, Iannone F, Cantarini L.

Isr Med Assoc J. 2018 Jul;20(7):438-441.

21.

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients.

Fabiani C, Vitale A, Rigante D, Emmi G, Bitossi A, Lopalco G, Sota J, Guerriero S, Orlando I, Gentileschi S, Iannone F, Frediani B, Galeazzi M, Vannozzi L, Tosi GM, Cantarini L.

Clin Rheumatol. 2019 Feb;38(2):407-415. doi: 10.1007/s10067-018-4228-6. Epub 2018 Aug 11.

PMID:
30099655
22.

Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease.

Sota J, Vitale A, Rigante D, Orlando I, Lucherini OM, Simpatico A, Lopalco G, Franceschini R, Galeazzi M, Frediani B, Fabiani C, Tosi GM, Cantarini L.

Isr Med Assoc J. 2018 Aug;20(8):517-521.

23.

Effect of PCM on the Hydration Process of Cement-Based Mixtures: A Novel Thermo-Mechanical Investigation.

Fabiani C, Pisello AL, D'Alessandro A, Ubertini F, Cabeza LF, Cotana F.

Materials (Basel). 2018 May 23;11(6). pii: E871. doi: 10.3390/ma11060871.

24.

Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study.

Sota J, Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, Manna R, Cimaz R, Priori R, Talarico R, de Marchi G, Frassi M, Gallizzi R, Soriano A, Alessio M, Cammelli D, Maggio MC, Gentileschi S, Marcolongo R, La Torre F, Fabiani C, Colafrancesco S, Ricci F, Galozzi P, Viapiana O, Verrecchia E, Pardeo M, Cerrito L, Cavallaro E, Olivieri AN, Paolazzi G, Vitiello G, Maier A, Silvestri E, Stagnaro C, Valesini G, Mosca M, de Vita S, Tincani A, Lapadula G, Frediani B, De Benedetti F, Iannone F, Punzi L, Salvarani C, Galeazzi M, Angotti R, Messina M, Tosi GM, Rigante D, Cantarini L; “Working Group” of Systemic Autoinflammatory Diseases of SIR (Italian Society of Rheumatology).

Clin Rheumatol. 2018 Aug;37(8):2233-2240. doi: 10.1007/s10067-018-4119-x. Epub 2018 May 17.

PMID:
29770930
25.

Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies.

Fabiani C, Sota J, Rigante D, Vitale A, Emmi G, Lopalco G, Vannozzi L, Guerriero S, Bitossi A, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Rheumatol. 2018 Oct;37(10):2805-2809. doi: 10.1007/s10067-018-4133-z. Epub 2018 May 15.

PMID:
29766375
26.

The eye involvement in monogenic autoinflammatory diseases: literature review and update.

Sota J, Vitale A, Fabiani C, Frediani B, Rigante D, Tosi GM, Zannin ME, Cantarini L.

Clin Exp Rheumatol. 2018 Jan-Feb;36 Suppl 110(1):44-53. Epub 2018 May 3. Review.

27.

Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases.

Lucherini OM, Rigante D, Sota J, Fabiani C, Obici L, Cattalini M, Gattorno M, Cantarini L.

Clin Exp Rheumatol. 2018 Jan-Feb;36 Suppl 110(1):3-9. Epub 2018 May 3. Review.

28.

The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model.

Criscuolo C, Cerri E, Fabiani C, Capsoni S, Cattaneo A, Domenici L.

Neurobiol Aging. 2018 Jul;67:181-188. doi: 10.1016/j.neurobiolaging.2018.03.017. Epub 2018 Mar 23.

PMID:
29735432
29.

Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement.

Emmi G, Vitale A, Silvestri E, Boddi M, Becatti M, Fiorillo C, Fabiani C, Frediani B, Emmi L, Di Scala G, Goldoni M, Bettiol A, Vaglio A, Cantarini L, Prisco D.

Arthritis Rheumatol. 2018 Sep;70(9):1500-1507. doi: 10.1002/art.40531. Epub 2018 Jul 19.

30.

Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumab.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, di Scala G, Guerriero S, Orlando I, Franceschini R, Capozzoli M, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Rheumatol. 2018 Jun;37(6):1715-1720. doi: 10.1007/s10067-018-4092-4. Epub 2018 Apr 18.

PMID:
29671190
31.

A novel pharmacological activity of caffeine in the cholinergic system.

Fabiani C, Murray AP, Corradi J, Antollini SS.

Neuropharmacology. 2018 Jun;135:464-473. doi: 10.1016/j.neuropharm.2018.03.041. Epub 2018 Mar 31.

PMID:
29614315
32.

Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis.

Fabiani C, Vitale A, Emmi G, Bitossi A, Lopalco G, Sota J, Guerriero S, Orlando I, Capozzoli M, Fusco F, Rana F, Iannone F, Frediani B, Galeazzi M, Vannozzi L, Tosi GM, Cantarini L.

Clin Rheumatol. 2019 Jan;38(1):63-70. doi: 10.1007/s10067-018-4069-3. Epub 2018 Apr 3.

PMID:
29611087
33.

Visual Evoked Potentials in Glaucoma and Alzheimer's Disease.

Cerri E, Fabiani C, Criscuolo C, Domenici L.

Methods Mol Biol. 2018;1695:69-80. doi: 10.1007/978-1-4939-7407-8_7.

PMID:
29190019
34.

Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis.

Fabiani C, Sota J, Vitale A, Emmi G, Vannozzi L, Bacherini D, Lopalco G, Guerriero S, Venerito V, Orlando I, Franceschini R, Fusco F, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Ocul Immunol Inflamm. 2019;27(1):34-39. doi: 10.1080/09273948.2017.1391297. Epub 2017 Nov 3.

PMID:
29099660
35.

Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet's Disease.

Fabiani C, Sota J, Rigante D, Vitale A, Emmi G, Vannozzi L, Franceschini R, Bacherini D, Frediani B, Galeazzi M, Tosi GM, Cantarini L.

Ocul Immunol Inflamm. 2019;27(1):58-63. doi: 10.1080/09273948.2017.1351573. Epub 2017 Oct 5.

PMID:
28981395
36.

Ustekinumab efficacy and safety in mucocutaneous multi-refractory Behçet's disease.

Lopalco G, Fabiani C, Venerito V, Lapadula G, Iannone F, Cantarini L.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):130-131. Epub 2017 Sep 7. No abstract available.

PMID:
28980903
37.

Diagnostic Criteria for Adult-Onset Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome.

Cantarini L, Vitale A, Sicignano LL, Emmi G, Verrecchia E, Patisso I, Cerrito L, Fabiani C, Cevenini G, Frediani B, Galeazzi M, Rigante D, Manna R.

Front Immunol. 2017 Aug 24;8:1018. doi: 10.3389/fimmu.2017.01018. eCollection 2017.

38.

Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma.

Orlando I, Vitale A, Rigante D, Lopalco G, Fabiani C, Cantarini L.

Intern Med J. 2017 Sep;47(9):1086-1088. doi: 10.1111/imj.13538. No abstract available.

PMID:
28891187
39.

Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study.

Fabiani C, Sota J, Vitale A, Rigante D, Emmi G, Vannozzi L, Bacherini D, Lopalco G, Guerriero S, Gentileschi S, Capozzoli M, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Br J Ophthalmol. 2018 May;102(5):637-641. doi: 10.1136/bjophthalmol-2017-310733. Epub 2017 Aug 26.

PMID:
28844047
40.

Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy.

Fabiani C, Vitale A, Orlando I, Capozzoli M, Fusco F, Rana F, Franceschini R, Sota J, Frediani B, Galeazzi M, Marco Tosi G, Cantarini L.

Isr Med Assoc J. 2017 Aug;19(8):478-483.

41.

Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease.

Fabiani C, Emmi G, Lopalco G, Vannozzi L, Bacherini D, Guerriero S, Franceschini R, Frediani B, Iannone F, Marco Tosi G, Rigante D, Cantarini L.

Isr Med Assoc J. 2017 Jul;19(7):415-419.

42.

Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.

Sota J, Rigante D, Lopalco G, Frediani B, Franceschini R, Galeazzi M, Iannone F, Tosi GM, Fabiani C, Cantarini L.

Rheumatol Int. 2018 Jan;38(1):25-35. doi: 10.1007/s00296-017-3775-5. Epub 2017 Jul 27. Review.

PMID:
28752230
43.

Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study.

Lopalco G, Emmi G, Gentileschi S, Guerriero S, Vitale A, Silvestri E, Becatti M, Cavallo I, Fabiani C, Frediani B, Iannone F, Cantarini L.

Mod Rheumatol. 2017 Nov;27(6):1031-1035. doi: 10.1080/14397595.2017.1285857. Epub 2017 Feb 21.

PMID:
28712320
44.

Quality of life impairment in Behçet's disease and relationship with disease activity: a prospective study.

Fabiani C, Vitale A, Orlando I, Sota J, Capozzoli M, Franceschini R, Galeazzi M, Tosi GM, Frediani B, Cantarini L.

Intern Emerg Med. 2017 Oct;12(7):947-955. doi: 10.1007/s11739-017-1691-z. Epub 2017 Jun 15.

PMID:
28620840
45.

Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema.

Fabiani C, Vitale A, Emmi G, Lopalco G, Vannozzi L, Bacherini D, Guerriero S, Favale RA, Fusco F, Franceschini R, Frediani B, Iannone F, Galeazzi M, Tosi GM, Cantarini L.

J Ocul Pharmacol Ther. 2017 Sep;33(7):549-555. doi: 10.1089/jop.2017.0034. Epub 2017 May 30.

PMID:
28557602
46.

IL-6 blockade in the management of non-infectious uveitis.

Lopalco G, Fabiani C, Sota J, Lucherini OM, Tosi GM, Frediani B, Iannone F, Galeazzi M, Franceschini R, Rigante D, Cantarini L.

Clin Rheumatol. 2017 Jul;36(7):1459-1469. doi: 10.1007/s10067-017-3672-z. Epub 2017 May 20. Review.

PMID:
28528519
47.

Controlled, prospective, observational study on the efficiency and tolerability of a combination of potential Nrf2-inducing antioxidants and micronutrients as pre-treatment for ICSI in dyspermic patients with previous failure.

Rago R, Gallo M, Dal Lago A, Licata E, Paciotti G, Amodei M, Meneghini C, Fabiani C, Dani G, Liberanome C, Antonaci D, Corno R, Miriello D, Giuffrida G, Giammusso B.

Eur Rev Med Pharmacol Sci. 2017 Apr;21(7):1645-1652.

48.

2-Acetyl-5-tetrahydroxybutyl imidazole (THI) protects 661W cells against oxidative stress.

Fabiani C, Zulueta A, Bonezzi F, Casas J, Ghidoni R, Signorelli P, Caretti A.

Naunyn Schmiedebergs Arch Pharmacol. 2017 Jul;390(7):741-751. doi: 10.1007/s00210-017-1374-3. Epub 2017 Apr 13.

PMID:
28409209
49.

Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease.

Vitale A, Emmi G, Lopalco G, Fabiani C, Gentileschi S, Silvestri E, Gerardo DS, Iannone F, Frediani B, Galeazzi M, Lapadula G, Rigante D, Cantarini L.

Clin Rheumatol. 2017 Sep;36(9):2063-2069. doi: 10.1007/s10067-017-3627-4. Epub 2017 Apr 11. Erratum in: Clin Rheumatol. 2018 Sep 22;:.

PMID:
28401434
50.

Cytokine Signatures in Mucocutaneous and Ocular Behçet's Disease.

Lopalco G, Lucherini OM, Lopalco A, Venerito V, Fabiani C, Frediani B, Galeazzi M, Lapadula G, Cantarini L, Iannone F.

Front Immunol. 2017 Feb 27;8:200. doi: 10.3389/fimmu.2017.00200. eCollection 2017.

Supplemental Content

Loading ...
Support Center